10th RSC-BMCS Fragment-based Drug Discovery Meeting
WuXi AppTec is pleased to participate in the 10th RSC-BMCS Fragment-based Drug Discovery Meeting, taking place September 14–16, 2026, in Cambridge, United Kingdom. The meeting brings together researchers advancing fragment screening, structural biology, biophysics, and medicinal chemistry to identify and optimize new starting points for challenging drug targets.
Successfully progressing a fragment hit requires sensitive screening methods, robust validation, structural insight, and close integration between chemistry and biology. WuXi AppTec supports this process through capabilities in fragment library screening, biophysical and biochemical hit validation, structural biology, computational chemistry, medicinal chemistry, biology, DMPK, and pharmacology. Our multidisciplinary teams apply structure-guided design, fragment growing, merging, and linking strategies to help transform early hits into potent, selective, and development-ready lead compounds.
Visit us at Booth 6 to meet our scientists and discuss how WuXi AppTec’s integrated platform can support your program from fragment screening and hit confirmation through lead optimization and candidate selection.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
